ARGNF:OTCMKTS
argenx SE
790,15 US$
0,00%
(0,00) 1D
13 ოქტ, 10:39:58 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ARGNF...
Mkt. cap
51,23 მლრდ.
Avg. vol.
14,00
Volume
0,00
52-wk high
1 020,00 US$
52-wk low
708,72 US$
Beta
0,46
Shares outstanding
62,89 მლნ.
No. of employees
2 ათ.
Mkt. cap
51,23 მლრდ.
Avg. vol.
14,00
Volume
0,00
52-wk high
1 020,00 US$
52-wk low
708,72 US$
Beta
0,46
Shares outstanding
62,89 მლნ.
No. of employees
2 ათ.
News stories
From web sources and news partners
ad-hoc-news.de
·
3 საათის წინ
Goldman lifts target for Argenx stock to EUR 959.00
Yahoo Finance
·
5 საათის წინ
Zacks Investment Ideas feature highlights: Cummins, Argenx and PACCAR
ad-hoc-news.de
·
7 საათის წინ
argenx sets October 22 results date as Argenx stock costs EUR 761.20
ad-hoc-news.de
·
10 საათის წინ
argenx schedules third-quarter results for October 22: stock pre-market at EUR 756.30
Profile
Argenx SE is a Belgian-Dutch pharmaceutical company specializing in immunology. Argenx specializes in the development of antibody therapies for the treatment of autoimmune diseases and cancer. Its work primarily focuses on the development of orphan drugs. Wikipedia
About argenx SE